Scholar Rock, Inc.
Clinical trials sponsored by Scholar Rock, Inc., explained in plain language.
-
New drug aims to help people lose fat, not muscle
Disease control CompletedThis study tested whether adding a new drug called apitegromab to a standard weight loss medication could help overweight and obese adults. The main goal was to see if the combination helped people lose more body fat while preserving their lean muscle mass. Researchers measured c…
Phase: PHASE2 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Muscle-Boosting drug shows promise for children with rare neuromuscular disease
Disease control CompletedThis completed Phase 3 trial tested whether adding the experimental drug apitegromab to standard SMA treatments could improve muscle function in 188 children and young adults (ages 2-21) with later-onset spinal muscular atrophy. All participants were already receiving approved SM…
Phase: PHASE3 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC